Frank Ruderman is the Executive Chairman of CardioRisk Laboratories.
Prior to joining CardioRisk Laboratories, Mr. Ruderman was the President and CEO of Berkeley Heart Labs where he led the company to over $100MM in revenue from just over $1MM. Mr. Ruderman orchestrated the sale of Berkeley Heart Labs to Celera, a publically traded company, for $195MM. Mr. Ruderman had been a consultant and a director of Genomyx from its founding at Genentech with Human Genome Project funding, later acting as President/CEO and CFO. Genomyx was sold to Beckman Instruments. He founded and acted President, COO and a Director of Physiometrix, which went public at a $60MM valuation. Mr. Ruderman also helped to found two additional medical device companies, Intella Interventional (private) and Cardiac Pathways (public at a $200MM valuation) as spin-outs of Physiometrix. Mr. Ruderman served as a Board member, President, COO and CFO of American Bionetics, which saw revenue growth of 5x and its stock price increased to a high of 8x, the IPO price. The Company was sold to BioGenex after finalizing two acquisitions and completing joint ventures with Millipore and Dupont. He served as a member of the Board and the first President/CEO of Mast Immunosystems, which was sold to Hitachi. Before that, Mr. Ruderman served in various domestic and international corporate executive positions with Pfizer Pharmaceuticals, Pfizer Diagnostics and Millipore.
Mr. Ruderman has an M.B.A. from the Amos Tuck School of Business at Dartmouth College, an M.A. in vascular physiology from Boston University, and a B.S. in biology from Tufts University.
Chief Executive Officer
Todd Eldredge currently serves as President and Chief Executive Officer at CardioRisk as well as a member of the board of directors. Todd directs all activities of the company with a focus on new technology, quality, and marketing. Todd brings more than 15 years of industry management experience to the company. Over his career, Todd has held a number of senior-level management positions within pharmaceutical and other high-tech companies. Todd has served in executive and management positions at STSN, Document Control Systems, and Sanofi-Aventis / Rhone Poulenc.
Prior to joining CardioRisk, Todd served as Vice President of Sales and Vice President / General Manager for STSN (now iBahn), a successful start-up that became the worldwide leader in broadband services for business travelers. The business currently serves hundreds of thousands of hotel rooms in hundreds of cities around the world. He also served as Vice President of Sales and Marketing at Document Control Systems (DCS) a quality systems enterprise software solution for Fortune 1000 companies. Prior to DCS, Todd ran a business unit for Rhone-Poulenc, which was eventually purchased by Aventis (now Sanofi-Aventis), a publicly-traded company.
Todd holds an MBA from Brigham Young University.
Bradley T. Nielson
Brad Nielson currently serves as President at CardioRisk and oversees operational and financial matters. He brings more than 20 years of successful leadership and managerial experience to the company. Over his career, Brad has held a number of C-level positions within manufacturing and high-tech companies.
Prior to joining CardioRisk, Brad served as President and CEO of MITY Enterprises, a publicly traded manufacturer of institutional furniture. He also served as their CFO during MITY’s 1994 initial public offering. Before joining Mity-Lite, he spent two years as the Vice President of Finance for Pinnacle Micro, Inc., a high tech manufacturer of optical storage equipment. He was instrumental in completing Pinnacle’s IPO and completing the $80 million sale MITY to a private equity group. He also spent several years as a management consultant with Price Waterhouse and Ernst & Young earlier in his career.
Brad graduated summa cum laude from Brigham Young University with a B.S. in accounting and a Masters of Business Administration. He is a CPA, a CFM and a CMA. He currently serves on several for-profit and non-for-profit boards.
Executive Vice President, Business Development
Kim serves as Executive Vice President, Business Development at CardioRisk. Kim brings 25 years of management experience to the company having successfully built national companies from the ground floor into multi-million dollar entities for acquisition.
Kim oversees all of the business development activities of the company and is hands-on in his approach, interfacing daily with customers and employees and maintaining strong relationships with the company\’s strategic alliances.
Prior to joining CardioRisk, Kim served as administrator for Total HomeCare, a multi-state home care company he built into a multi-million dollar entity. Kim also served as President and CEO of All American Festivals, the largest national special event company producing bowl game halftime shows and music festivals throughout North America.